(founded in 2003, 358 employees) Focus on pharmaceutical contract manufacturing (GMP production, packaging of solid enzyme products, liquid and semi-solid medicines). Part of aenova group since 2014.
(in the BioPark, founded in 2002, 3 employees) develops and markets cell culture technology based on human liver cells and other human organs for novel drug development and new therapy for liver cell transplantation.
The Human Tissue and Cell Research (HTCR) Foundation regards the use of human in vitro models as a potent medical research instrument of high clinical relevance. Therefore it ascribes the development of new and improved in vitro techniques for the research into pathophysiological connections in human tissue and the resulting diagnostic and cell-based therapeutic options to be of central importance to this process.
(founded in 2008, 2 employees) works on commercial application of hyperthermophile microorganisms, screening and culturing of all kinds of hyperthermophiles for industrial applications.